HESC DIFFERENTIATION

Generation of Striatal Neurons from Mouse and Human Embryonic Stem Cells: its Relevance for Regenerative Medicine in Huntington's Disease and for Studying Striatal Development

Coordinatore	UNIVERSITA DEGLI STUDI DI MILANO    more  Organization address address: Via Festa Del Perdono 7 city: MILANO postcode: 20122 contact info Titolo: Mr. Nome: Sergio Cognome: Longo Email: send email Telefono: +39 2 50318335 Fax: +39 2 50318284
Nazionalità Coordinatore	Italy [IT]
Totale costo	100˙000 €
EC contributo	100˙000 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2010-RG
Funding Scheme	MC-IRG
Anno di inizio	2010
Periodo (anno-mese-giorno)	2010-11-01   -   2014-10-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	UNIVERSITA DEGLI STUDI DI MILANO  Organization address address: Via Festa Del Perdono 7 city: MILANO postcode: 20122 contact info Titolo: Mr. Nome: Sergio Cognome: Longo Email: send email Telefono: +39 2 50318335 Fax: +39 2 50318284	IT (MILANO)	coordinator	100˙000.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Huntington’s disease (HD) is an autosomal-dominant, progressive neurodegenerative disorder that usually onsets in midlife. It is characterized by motor, cognitive, and psychiatric symptoms. Once symptomatic, patients are rapidly disabled and require increasing multidisciplinary care. HD is a tremendous burden for medical, social, and family resources. The symptoms and the progression of HD can be linked to its neuropathology, which is characterized by loss of specific neuronal populations in many brain regions. The most important and best studied neuropathology is found in the basal ganglia, in particular a gross atrophy of the striatum. The striatum is characterized by different neuronal populations. Several studies have shown that medium spiny neurons (MSN) are severely affected in HD. MSN are inhibitory projection neurons and are the primary source of striatal projections.Existing medical strategies are available to alleviate some symptoms of HD, including symptomatic therapies (for movements disorders, cognitive impairment, and behavioural manifestations), neuroprotective therapies (anti-glutamatergic drugs), and preventive therapies (for anticipating the clinical onset). Nevertheless, it remains clear that the progressive neurodegenerative process is essentially untreatable medically. For this reason new regenerative therapies that replace neuronal populations and restore function are of great interest and a mandatory research field. This proposal aims at developing new strategies for producing fully functional human striatal neurons from hES with the goal of a future transplantation in HD.'